University of Cincinnati Cancer Center

Cincinnati, Ohio 45267

8 studies enrolling now · 23 studies all time

What they study most

Advanced Cancer, Advanced Solid Tumor, Advanced or Metastatic Solid Tumors, Anaplastic Lymphoma Kinase-positive, Cervical Cancer, Colo-rectal Cancer, Colorectal Cancer, Cutaneous Melanoma, Endometrial Adenocarcinoma, Endometrial Cancer, Epithelial Tumor, Esophageal Adenocarcinoma

Studies at this site

• A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembrolizumab Versus Pembrolizumab Alone for Patients With a Form of Head and Neck Cancer Positive for Human Papilloma Virus 16 and Expressing the Protein PD-L1 — Recruiting now
• Study of Daraxonrasib and Daraxonrasib + GnP as First-line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma — Recruiting now
• Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC — Recruiting now
• A Phase 2 Study of ACR-368 in Endometrial Adenocarcinoma — Recruiting now
• Study of IDE196 in Patients With Solid Tumors Harboring GNAQ/11 Mutations or PRKC Fusions — Recruiting now
• A Phase 1 Study Evaluating DISP-10 in Participants With Advanced Gastrointestinal Cancers — Recruiting now
• Study of SGN1 in Patients With Advanced Solid Tumor — Recruiting now
• Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC — Recruiting now
• Safety and Tolerability Study of GIM-531 in Advanced Solid Tumors — Recruiting now
• A Study Comparing Anitocabtagene Autoleucel to Standard of Care Therapy in Participants With Relapsed/ Refractory Multiple Myeloma — Running, not enrolling
• Study of NXC-201 CAR-T in Patients With Light Chain (AL) Amyloidosis — Running, not enrolling
• A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer — Running, not enrolling
• A Study Evaluating DS-1055a in Participants With Relapsed or Refractory Locally Advanced or Metastatic Solid Tumors — Running, not enrolling
• Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage — Stopped early
• The BURAN Study of Buparlisib in Patients With Recurrent or Metastatic HNSCC — Completed
• A Study Investigating AGEN1777 in Participants With Advanced Solid Tumors — Completed
• TAC T-cells for the Treatment of HER2-positive Solid Tumors — Stopped early
• Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours — Completed
• A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors — Running, not enrolling
• A Study Investigating agenT-797 in Participants With Relapsed/Refractory Solid Tumors — Completed
• Pancreas Cancer: Molecular Profiling as a Guide to Therapy Before and After Surgery ("Personalized Medicine") — Completed
• agenT-797 in Participants With Relapsed/Refractory Multiple Myeloma — Completed
• Gemcitabine and ON 01910.Na in Previously Untreated Metastatic Pancreatic Cancer — Completed